Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1762617 (
weakness
)
37,932
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Mutations in Sigma 1 receptor (
SIGMAR1
) have been previously identified in patients with amyotrophic lateral sclerosis and disruption of Sigmar1 in mouse leads to locomotor deficits. However, cellular mechanisms underlying motor phenotypes in human and mouse with disturbed
SIGMAR1
function have not been described so far. Here we used a combination of in vivo and in vitro approaches to investigate the role of
SIGMAR1
in motor neuron biology. Characterization of Sigmar1(-/-) mice revealed that affected animals display locomotor deficits associated with muscle
weakness
, axonal degeneration and motor neuron loss. Using primary motor neuron cultures, we observed that pharmacological or genetic inactivation of
SIGMAR1
led to motor neuron axonal degeneration followed by cell death. Disruption of
SIGMAR1
function in motor neurons disturbed endoplasmic reticulum-mitochondria contacts, affected intracellular calcium signalling and was accompanied by activation of endoplasmic reticulum stress and defects in mitochondrial dynamics and transport. These defects were not observed in cultured sensory neurons, highlighting the exacerbated sensitivity of motor neurons to
SIGMAR1
function. Interestingly, the inhibition of mitochondrial fission was sufficient to induce mitochondria axonal transport defects as well as axonal degeneration similar to the changes observed after
SIGMAR1
inactivation or loss. Intracellular calcium scavenging and endoplasmic reticulum stress inhibition were able to restore mitochondrial function and consequently prevent motor neuron degeneration. These results uncover the cellular mechanisms underlying motor neuron degeneration mediated by loss of
SIGMAR1
function and provide therapeutically relevant insight into motor neuronal diseases.
...
PMID:Dysfunction in endoplasmic reticulum-mitochondria crosstalk underlies SIGMAR1 loss of function mediated motor neuron degeneration. 2608 64
Distal hereditary motor neuropathies represent a group of rare genetic disorders characterized by progressive distal motor
weakness
without sensory loss. Their genetic heterogeneity is high and thus eligible for diagnostic whole exome sequencing. The authors report successful application of whole exome sequencing in diagnosing a second consanguineous family with distal hereditary motor neuropathy due to a homozygous c.151+1G>T variant in
SIGMAR1
. This variant was recently proposed as causal for the same condition in a consanguineous Chinese family. Compared to this family, the Afghan ethnic origin of our patient is distinct, yet the features are identical, validating the
SIGMAR1
deficiency phenotype: progressive muscle wasting/
weakness
in lower and upper limbs without sensory loss. Rapid disease progression during adolescent growth is similar and may be due to
SIGMAR1
's role in regulating axon elongation and tau phosphorylation. Finally, the authors conclude that
SIGMAR1
deficiency should be added to the differential diagnosis of distal hereditary motor neuropathies.
...
PMID:Further Validation of the
SIGMAR1
c.151+1G>T Mutation as Cause of Distal Hereditary Motor Neuropathy. 2850 17
SIGMAR1
gene encodes a non-opioid endoplasmic reticulum (ER) protein which is involved in a large diversity of cell functions and is expressed ubiquitously in both central and peripheral nervous systems. Alterations of its normal function may contribute to two different phenotypes: juvenile amyotrophic lateral sclerosis (ALS 16) and distal hereditary motor neuropathies (dHMN). We present the case of a female patient, of 37-years-old, with distal muscle
weakness
and atrophy beginning in childhood and slowly progressive in the first two decades of life. Neurological examination revealed a symmetrical severe muscle wasting and
weakness
in distal lower and upper limbs, with claw hands, footdrop with equinovarus deformity and hammer toes, generalized areflexia and normal sensory examination. The electrodiagnostic study revealed a pure chronic motor peripheral nerve involvement without signs of demyelination. The molecular study found the deletion c.561_576del on exon 4 and a deletion of all exon 4, in the
SIGMAR1
gene.
...
PMID:
SIGMAR1
gene mutation causing Distal Hereditary Motor Neuropathy in a Portuguese family. 3007 98